Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro

Experimental Parasitology

Volumn 115, Issue 4, 2007, Pages 387-392

  Min, T H ^a   Khairul, M F M ^a   Low, J H ^a   Che Nasriyyah, C H ^a   A'shikin, A Noor ^a   Norazmi, M N ^b   Ravichandran, M ^a   Raju, S S ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Chloroquine resistance; Mefloquine resistance; p glycoprotein inhibitor; Plasmodium falciparum; Roxithromycin

Indexed keywords

CHLOROQUINE; MEFLOQUINE; ROXITHROMYCIN; VERAPAMIL;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; IC 50; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; DRUG SYNERGISM; INHIBITORY CONCENTRATION 50; MEFLOQUINE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; ROXITHROMYCIN;

PLASMODIUM FALCIPARUM;

EID: 33846621061     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.10.004     Document Type: Article

References (27)

1. Anderson S.L., Ager A., McGreevy P., Schuster B.G., Wesche D., Kuschner R., Ohrt C., Ellis W., Rossan R., and Berman J. Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. The American Journal of Tropical Medicine and Hygiene 52 (1995) 159-161
2. Biswas S. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. Journal Postgraduate Medicine 47 (2001) 240-243
3. Bouvier d'Yvoire M.J., Dresco I.A., and Tulkens P.M. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. Journal of Antimicrobial Chemotherapy 41 Suppl. B (1998) 63-68
4. Bruce-Chwatt, L.J., Black, R.H., Canfield, C.J., Clyde, D.F., Peters, W., Wernsdorfer, W.H., 1986. In: Bruce-Chwatt, L.J (Ed.), Chemotherapy of Malaria World Health Organization, Geneva.
5. Corallo C.E., and Rogers I.R. Roxithromycin-induced digoxin toxicity. The Medical Journal of Australia 165 (1996) 433-434
6. Cowman A.F., Karcz S., Galatis D., and Culvenor J.G. A P-glycoprotein homolog of Plasmodium falciparum is localized on the digestive vacuole. The Journal of Cell Biology 113 (1991) 1033-1042
7. Desjardins R.E., Canfield C.J., Haynes J.D., and Chulay J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy 16 (1979) 710-718
8. Donta S.T. Macrolide therapy of chronic lyme disease. Medical Science Monitor 9 (2003) 1136-1142
9. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M.J., Forsyth K., Kemp D.J., and Cowman A.F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345 (1990) 255-258
10. Ishiguro M., Koga H., Kohno S., Hayashi T., Yamaguchi K., and Hirota M. Penetration of macrolides into human polymorphonuclear leucocytes. Journal of Antimicrobial and Chemotherapy 24 (1989) 719-729
11. Kanfer I., Skinner M.F., and Walker R.B. Review: analysis of macrolide antibiotics. Journal of Chromatography. A 812 (1998) 255-286
12. Kondrachine A.V., and Trigg P.I. Global overview of malaria. The Indian Journal of Medical Research 106 (1997) 39-52
13. Labro M.T. Intracellular penetration of macrolides. Presse Medicale 2 (1997) 11-15
14. Lassman H.B., Puri S.K., Ho I., Sabo R., and Mezzino M.J. Pharmacokinetics of roxithromycin (RU 965). Journal of Clinical Pharmacology 28 (1988) 141-152
15. Martin S.K., Oduola A.M., and Milhous W.K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235 (1987) 899-901
16. Noronha E., Alecrim M.G., Romero G.A., and Macedo V. [RIII mefloquine resistance in children with falciparum malaria in Manaus, AM, Brazil]. Revista da Sociedade Brasileria de Medicina Tropical 33 2 (2000) 201-205
17. Ohrt C., Willingmyre G.D., Lee P., Charles K., and Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum In Vitro. Antimicrobial Agents and Chemotherapy 46 (2002) 2518-2524
18. Pechere J.C. New perspectives on macrolide antibiotics. International Journal of Antimicrobial Agents 18 (2001) S93-S97
19. Pradines B., Rogier C., Fusai T., Mosnier J., Daries W., Barret E., and Parzy D. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by Iron. Antimicrobiology Agents and Chemotherapy 45 (2001) 1746-1750
20. Price R.N., Uhlemann A.C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N.J., Nosten F., and Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364 (2004) 438-447
21. Puri S.K., and Lassman H.B. Roxithromycin: a pharmacokinetic review of a macrolide. The Journal of Antimicrobial Chemotherapy 20 (1987) 89-100
22. Taylor W.R., Widjaja H., Richie T.L., Basri H., Ohrt C., Tjitra, Taufik E., Jones T.R., Kain K.C., and Hoffman S.L. Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in Northeastern Irian Jaya, Indonesia. The American Journal of Tropical Medicine and Hygiene 64 (2001) 223-238
23. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
24. Wichmann O., Betschart B., Loscher T., Nothdurft H.D., Sonnenburg F.V., and Jelinek T. Prophylaxis failure due to probable mefloquine resistant P. falciparum from Tanzania. Acta Tropica 86 1 (2003) 6
25. Wise R., Kirkpatrick B., Ashby J., and Andrews M. Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing. Antimicrobial Agents and Chemotherapy 31 (1987) 1051-1053
26. Yayon A., Cabantchik Z.I., and Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. The EMBO Journal 3 (1984) 2695-2700
27. Yeo A.E., and Riekmann K.H. Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. International Journal for Parasitology 25 (1995) 531-532